AACR: Progress treating pancreatic cancer, immunotherapy for head and neck cancers, potential biomarker for aggressive neuroendocrine carcinomas and more
The annual meeting will feature more than 40 regular, late-breaking and clinical trial abstracts from UCLA physicians and scientists, who will present their lat